Is Summit Therapeutics, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Summit Therapeutics, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST are both mildly bearish. The Bollinger Bands show a bullish signal on the monthly timeframe, which contrasts with the mildly bearish indicators on the weekly timeframe. Overall, the mixed signals suggest a cautious bullish outlook.
In terms of performance, the stock has outperformed the S&P 500 over the past week with a return of 2.29% compared to the S&P 500's 1.09%, but it has underperformed over the past month with a return of -8.89% versus the S&P 500's 4.15%. Year-to-date, the stock has returned 20.09%, outperforming the S&P 500's 14.18%.